 |
|
|
9-June-2008:
Amira Pharmaceuticals Hires Industry Veteran for CFO Position<more>
2-June-2008:
Amira Pharmaceuticals achieves milestones in FLAP inhibitor program with GlaxoSmithKline GSK exercises option for AM803, a FLAP inhibitor which recently completed phase I studies<more>
31-March-2008:
Amira Pharmaceuticals today announced the appointment of two additional members to its board of directors: Dennis M. Fenton, Ph.D. and Stephen W. Kaldor, Ph.D. <more>
|
Two years since launch; $40 million invested; four novel
compounds discovered. Download
our fact sheet for an overview of Amira. PDF
Keep pace with developments at Amira by signing up for regular email
alerts. Sign up here.
|
